RCM staff shortages are making harder for providers to get paid

The latest stories trending on MedCity News.

Editor's Pick

Top Story RCM Staff Shortages Are Making It a Lot Harder for Providers to Get Paid Discussions around healthcare's workforce crisis usually center around providers' lack of clinicians, but there's a sweeping shortage of revenue cycle workers, too. In a new report, Experian Health surveyed 200 employees who are responsible for staffing the revenue cycle function at providers — every respondent said that staff shortages are having a significant negative impact on their organization's ability to get paid for care and/or patient engagement. Sponsored Content Navigating Healthcare's Data Revolution: Priorities, Opportunities, and Challenges for Health Systems Presented by Arcadia Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here's what we found. Sponsored Content Heard at HLTH 2023: Surescripts Presented by Surescripts Dr. Lynne Nowak of Surescripts shares how clinicians will fill care gap needs as physician numbers are expected to fall in coming years. Watch Now

Featured News

Report: Percentage of Workers Eligible for Employment-Based Coverage Increased 5% Since 2014 It was expected that the Affordable Care Act would lead to many employers dropping health benefits, but that did not happen, a new report from the Employee Benefit Research Institute found. Why GLP-1s Alone Cannot Solve the Obesity Crisis People with obesity should be offered a range of suitable treatments as well: behavioral, nutrition, exercise, medication and surgery, through a coordinated and holistic approach under one roof, with a care coordinator. Like cancer, obesity is a heterogeneous disease and recommendations and responses to all treatment modalities will be heterogeneous as well. Celldex Drug Flashes Potential to Compete With, Maybe Beat Rival Big Pharma Meds Celldex drug barzolvolimab has mid-stage results in a chronic inflammatory skin disease that top those of an approved Genentech drug and two experimental Novartis therapies. The biotech is preparing to advance its drug to Phase 3 testing in 2024. Urban Institute: 400,000 Veterans Expected to be Uninsured in 2024 About half (47%) of nonelderly uninsured veterans will be eligible for Medicaid or subsidies through the ACA Marketplace in 2024, according to a new report from the Urban Institute. INVEST Digital Health Pitch Perfect Spotlight: Hera Is Building a Better Way to Diagnose Endometriosis Hera Biotech, a San Antonio-based startup developing a nonsurgical diagnostic test for endometriosis, won the Pitch Perfect contest at MedCity News' INVEST Digital Health conference. The average diagnostic delay for the endometriosis is eight years, driven in large part by the fact that the only method currently used to diagnose the disease is a surgical procedure. BMS Pays $100M for Next-Gen Orum Therapeutics ADC for Blood Cancers Bristol Myers Squibb is expanding its scope in cancer by acquiring rights to a Phase 1-ready Orum Therapeutics program that brings a new twist to antibody drug conjugates. The deal is the latest business development move in the hot field of ADCs.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Jeff Smith, CEO of Bamboo Health For October's guest interview, we are joined by Jeff Smith, who became the CEO of digital health company Bamboo Health this month. Before Bamboo, Smith held several leadership positions at Lumeris, a value-based care managed services operator for health systems. Before that, he spent more than six years in leadership roles at CVS. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe